ArticleBMC infectious diseases2026
Association between ABO/Rh blood groups and transfusion-transmitted infections among Turkish blood donors: a comprehensive demographic analysis (2015-2021).
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study assessed associations between transfusion-transmitted infections (TTIs: hepatitis B, hepatitis C, HIV, syphilis) and demographic factors (sex, age, education) including ABO/Rh blood groups among Turkish blood donors from 2015 to 2021.
methodsA retrospective cross-sectional analysis was performed on 56,766 donors confirmed with any TTI and permanently deferred from donation. The control group comprised 7,229,867 volunteer donors from the same period. Multivariable logistic regression analysis was conducted to assess independent associations between demographic factors and ABO/Rh blood groups with individual TTI risks, adjusting for potential confounders. False Discovery Rate correction was applied for multiple comparisons.
resultsOverall TTI prevalence was 0.779%, with HBV being most prevalent (0.594%), followed by syphilis (0.133%), HCV (0.031%), and HIV (0.024%). TTI prevalence decreased significantly over the study period. Male donors showed higher adjusted risk for all TTIs. Lower education levels (≤ 8 years) were associated with increased risk for all infections. Younger donors (18–34 years) had lower prevalence of HBV and syphilis compared to those ≥ 35 years. After FDR correction, several blood group associations remained significant: Blood group B Rh(+) showed increased risk for both HBV (aOR = 1.059, 95% CI: 1.032–1.088) and syphilis (aOR = 1.121, 95% CI: 1.062–1.184). AB Rh(+) donors had increased syphilis risk (aOR = 1.118, 95% CI: 1.035–1.206). Conversely, O Rh(+) showed protective association with syphilis (aOR = 0.855, 95% CI: 0.817–0.895), while A Rh(-) demonstrated protection against HBV (aOR = 0.935, 95% CI: 0.894–0.978). No significant associations were found between blood groups and HCV or HIV infections.
conclusionThis large-scale study demonstrates declining TTI prevalence in Turkish blood donors and identifies demographic risk factors including male sex, older age, and lower education. ABO/Rh blood groups show statistically significant but modest associations with specific TTIs, particularly HBV and syphilis. These findings suggest blood group systems may represent non-modifiable risk factors through complex immunological mechanisms. Comprehensive molecular and genetic studies are needed to elucidate underlying mechanisms and validate these population-specific associations. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.